No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Chart series for revenue are being prepared.
No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Chart series for revenue are being prepared.
The latest delayed quote for Instinct Bio Technical Co. Holdings Inc. (BIOT) stock was $0.39 as of Oct 6, 2026, 10:34 AM EDT, up 3.77% from the previous close.
An integrated regenerative medicine and longevity company focused on the research, manufacturing, and commercialization of regenerative health technologies, stem cell-derived products, wellness solutions, and advanced skincare.
Household & Personal Products · Grand Cayman
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
N/A
vs Estimate
N/A
Revenue
N/A
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1BIOT | $1.66M | $0.39 | +3.77% | N/A | N/A | N/A | N/A |
| 2IPST | $1.69M | $3.07 | -2.23% | -99.00% | N/A | N/A | vs BIOT |
| 3IBG | $1.71M | $0.94 | -0.64% | -94.23% | N/A | N/A | vs BIOT |
| 4BYAH | $1.79M | $2.39 | +3.91% | -98.78% | N/A | N/A | vs BIOT |
| 5AMSS | $1.44M | $0.43 | +2.19% | N/A | N/A | N/A | vs BIOT |
| 6MSS | $1.34M | $1.65 | +1.24% | -96.58% | N/A | N/A | vs BIOT |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$0.39
High
N/A